Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Liver Involvement in Children with Alpha-1 Antitrypsin Deficiency: A Multicenter Study

  • Cakir, Murat (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Karadeniz Technical University) ;
  • Sag, Elif (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Karadeniz Technical University) ;
  • Islek, Ali (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Ataturk University) ;
  • Baran, Masallah (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Katip Celebi University) ;
  • Tumgor, Gokhan (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Cukurova University) ;
  • Aydogdu, Sema (Department of Pediatric Gastroenterology Hepatology and Nutrition, Faculty of Medicine, Ege University)
  • Received : 2019.08.02
  • Accepted : 2020.01.10
  • Published : 2020.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Alpha-1 antitrypsin deficiency (A1ATD) in one of the most common genetic causes of liver disease in children. We aimed to analyze the clinical characteristics and outcomes of patients with A1ATD. Methods: This study included patients with A1ATD from five pediatric hepatology units. Demographics, clinical findings, genetics, and outcome of the patients were recorded (n=25). Results: Eight patients (32.0%) had homozygous PiZZ genotype while 17 (68.0%) had heterozygous genotype. Patients with PiZZ genotype had lower alpha-1 antitrypsin levels than patients with PiMZ genotype (37.6±7.7 mg/dL vs. 66.5±22.7 mg/dL, p=0.0001). Patients with PiZZ genotype were diagnosed earlier than patients with PiMZ genotype, but this was not significant (13±6.8 months vs. 23.7±30.1 months, p=0.192). Follow-up revealed the death of one patient (12.5%) with a homozygous mutation, and revealed that one patient had child A cirrhosis, five patients (62.5%) had chronic hepatitis, and one patient (12.5%) was asymptomatic. Nine of the 17 patients with a heterozygous mutation had chronic hepatitis (52.9%), two (11.7%) had child A cirrhosis, and six (35.2%) were asymptomatic. Overall, 18 (72%) of the 25 children had liver pathology in the long-term. Conclusion: Although prevalence is rare, patients with liver disorders should be checked for alpha-1 antitrypsin levels. Moreover, long-term follow-up is essential because most patients have a liver pathology.

Keywords

References

  1. Duvoix A, Roussel BD, Lomas DA. Molecular pathogenesis of alpha-1-antitrypsin deficiency. Rev Mal Respir 2014;31:992-1002. https://doi.org/10.1016/j.rmr.2014.03.015
  2. Hunt JM, Tuder R. Alpha 1 anti-trypsin: one protein, many functions. Curr Mol Med 2012;12:827-35. https://doi.org/10.2174/156652412801318755
  3. Silva D, Oliveira MJ, Guimaraes M, Lima R, Gomes S, Seixas S. Alpha-1-antitrypsin (SERPINA1) mutation spectrum: three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal. Respir Med 2016;116:8-18. https://doi.org/10.1016/j.rmed.2016.05.002
  4. Bals R. Alpha-1-antitrypsin deficiency. Best Pract Res Clin Gastroenterol 2010;24:629-33. https://doi.org/10.1016/j.bpg.2010.08.006
  5. Mitchell EL, Khan Z. Liver disease in Alpha-1 antitrypsin deficiency: current approaches and future directions. Curr Pathobiol Rep 2017;5:243-52. https://doi.org/10.1007/s40139-017-0147-5
  6. Fairbanks KD, Tavill AS. Liver disease in alpha 1-antitrypsin deficiency: a review. Am J Gastroenterol 2008;103:2136-41; quiz 2142. https://doi.org/10.1111/j.1572-0241.2008.01955.x
  7. Bakula A, Pawlowska J, Niewiadomska O, Jankowska I, Teisseyre M, Kalicinski P, et al. Liver transplantation in polish children with $\alpha$(1)-antitrypsin deficiency: a single-center experience. Transplant Proc 2016;48:3323-7. https://doi.org/10.1016/j.transproceed.2016.08.047
  8. Clark VC. Liver transplantation in alpha-1 antitrypsin deficiency. Clin Liver Dis 2017;21:355-65. https://doi.org/10.1016/j.cld.2016.12.008
  9. Bals R, Koczulla R, Kotke V, Andress J, Blackert K, Vogelmeier C. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med 2007;101:1708-14. https://doi.org/10.1016/j.rmed.2007.02.024
  10. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21. https://doi.org/10.1056/NEJM197606102942404
  11. Motamed F, Mehrabani S, Monajemzadeh M, Haghi Ashtiani MT, Hosseinverdi S, Houshmand M, et al. Low incidence of alpha-1-antitrypsin deficiency in Iranian patients with neonatal cholestasis. Turk J Gastroenterol 2015;26:251-3. https://doi.org/10.5152/tjg.2015.6339
  12. Aydogdu S, Arikan C, Kilic M, Ozgenc F, Akman S, Unal F, et al. Outcome of pediatric liver transplant recipients in Turkey: single center experience. Pediatr Transplant 2005;9:723-8. https://doi.org/10.1111/j.1399-3046.2005.00366.x
  13. Sari S, Egritas O, Baris Z, Unlusoy A, Bukulmez A, Dalgic B. Infantile cholestatic liver diseases: retrospective analysis of 190 cases. Turk Arch Ped 2012;47:167-73. https://doi.org/10.4274/tpa.701
  14. Growth Stages 1: Infancy and Early Childhood [Internet] [cited 2020 Feb 27]. Available from: http://sciencenetlinks.com/lessons/growth-stages-1-infancy-and-early-childhood/
  15. Comba A, Demirbas F, Caltepe G, Eren E, Kalayci AG. Retrospective analysis of children with $\alpha$-1 antitrypsin deficiency. Eur J Gastroenterol Hepatol 2018;30:774-8. https://doi.org/10.1097/MEG.0000000000001108
  16. Sveger T, Eriksson S. The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 1995;22:514-7. https://doi.org/10.1002/hep.1840220221
  17. van Hasselt PM, Kok K, Vorselaars AD, van Vlerken L, Nieuwenhuys E, de Koning TJ, et al. Vitamin K deficiency bleeding in cholestatic infants with alpha-1-antitrypsin deficiency. Arch Dis Child Fetal Neonatal Ed 2009;94:F456-60. https://doi.org/10.1136/adc.2008.148239
  18. Ekelund H. Late haemorrhagic disease in Sweden 1987-89. Acta Paediatr Scand 1991;80:966-8. https://doi.org/10.1111/j.1651-2227.1991.tb11763.x
  19. Graham RP, Dina MA, Howe SC, Butz ML, Willkomm KS, Murray DL, et al. SERPINA1 full-gene sequencing identifies rare mutations not detected in targeted mutation analysis. J Mol Diagn 2015;17:689-94. https://doi.org/10.1016/j.jmoldx.2015.07.002
  20. Massi G. Pathogenesis and pathology of liver disease associated with alpha 1-antitrypsin deficiency. Chest 1996;110(6 Suppl):251S-5S. https://doi.org/10.1378/chest.110.6_Supplement.251S
  21. Teckman JH. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy. COPD 2013;10 Suppl 1:35-43. https://doi.org/10.3109/15412555.2013.765839
  22. Teckman JH, Rosenthal P, Abel R, Bass LM, Michail S, Murray KF, et al.; Childhood Liver Disease Research Network (ChiLDReN). Baseline analysis of a young $\alpha$-1-antitrypsin deficiency liver disease cohort reveals frequent portal hypertension. J Pediatr Gastroenterol Nutr 2015;61:94-101. https://doi.org/10.1097/mpg.0000000000000753

Cited by

  1. Personalizing liver targeted treatments and transplantation for patients with alpha-1 antitrypsin deficiency vol.6, pp.1, 2021, https://doi.org/10.1080/23808993.2021.1862648